| Schedule of Provision For Income Taxes Differs From The Federal Statutory Rate |
Income
tax expense and the effective tax rate were as follows:
Schedule
of Income Tax Expense and the Effective Tax Rate
| | |
| | |
| |
| Financial Designation, Predecessor and Successor [Fixed List] | |
Successor | | |
Predecessor | |
| | |
Successor | | |
Predecessor | |
| | |
For the Three | | |
For the Three | |
| | |
Months Ended | | |
Months Ended | |
| | |
March 31, | | |
March 31, | |
| (in thousands) | |
2023 | | |
2022 | |
| | |
| | |
| |
| Income tax benefit | |
$ | 1,047,051 | | |
$ | - | |
| | |
| | | |
| | |
| Effective tax rate | |
| 22.81 | % | |
| 0.00 | % |
|
The
provision for income taxes differs from the Federal statutory rate as follows:
Schedule of Provision For Income Taxes Differs From The Federal Statutory Rate
| | |
December 31, 2022 | | |
December 12, 2022 | | |
December 31, 2021 | |
| Financial Designation, Predecessor and Successor [Fixed List] | |
Successor | | |
Predecessor | | |
Predecessor | |
| | |
Successor | | |
Predecessor | |
| | |
For the period | | |
For the period | | |
| |
| | |
December
13
through | | |
January
1
through | | |
For
the year
ended | |
| | |
December 31, 2022 | | |
December 12, 2022 | | |
December 31, 2021 | |
| | |
| | |
| | |
| |
| Federal statutory rate | |
| 21.0 | % | |
| 21.0 | % | |
| 21.0 | % |
| State tax rate, net of federal benefit | |
| 3.6 | % | |
| 3.6 | % | |
| 3.7 | % |
| Permanent items | |
| (1.9 | %) | |
| (5.4 | %) | |
| (0.9 | %) |
| Nondeductible basis difference | |
| 0.0 | % | |
| 0.0 | % | |
| 0.1 | % |
| Effect of change in state rate | |
| 0.0 | % | |
| (0.1 | %) | |
| 3.9 | % |
| Prior period adjustments and other | |
| 0.0 | % | |
| (0.1 | %) | |
| 0.0 | % |
| Change in valuation allowance | |
| 68.1 | % | |
| (19.0 | %) | |
| (27.8 | %) |
| Effective income tax rate | |
| 90.8 | % | |
| (0.0 | %) | |
| 0.0 | % |
|
| Schedule of Provision For Income Taxes |
|
The
provision for income taxes consists of the following (benefits) provisions:
Schedule of Provision For Income Taxes
| | |
December 31, 2022 | | |
December 12, 2022 | | |
December 31, 2021 | |
| Financial Designation, Predecessor and Successor [Fixed List] | |
Successor | | |
Predecessor | | |
Predecessor | |
| | |
Successor | | |
Predecessor | |
| | |
For the period | | |
For the period | | |
| |
| | |
December 13
through | | |
January 1
through | | |
For the year
ended | |
| | |
December 31, 2022 | | |
December 12, 2022 | | |
December 31, 2021 | |
| | |
| | |
| | |
| |
| Deferred tax benefit: | |
| | | |
| | | |
| | |
| Federal | |
$ | (151,625 | ) | |
$ | (2,191,344 | ) | |
$ | (1,480,472 | ) |
| State | |
| (34,844 | ) | |
| (482,283 | ) | |
| (763,612 | ) |
| Deferred tax benefit | |
| (186,469 | ) | |
| (2,673,627 | ) | |
| (2,244,084 | ) |
| Change in valuation allowance | |
| (558,581 | ) | |
| 2,673,627 | | |
| 2,244,084 | |
| Provision for income taxes | |
$ | (745,050 | ) | |
$ | - | | |
$ | - | |
|
| Schedule of Deferred Tax Assets and Liabilities |
|
Deferred
tax assets and liabilities consist of the following:
Schedule of Deferred Tax Assets and Liabilities
| | |
December 31, 2022 | | |
December 12, 2022 | | |
December 31, 2021 | |
| | |
Successor | | |
Predecessor | | |
Predecessor | |
| | |
Successor | | |
Predecessor | |
| | |
December 31, 2022 | | |
December 12, 2022 | | |
December 31, 2021 | |
| | |
| | |
| | |
| |
| Net operating loss carryforwards | |
$ | 6,671,907 | | |
$ | 6,639,882 | | |
$ | 4,930,055 | |
| Stock-based compensation expense | |
| 2,936,945 | | |
| 4,084,595 | | |
| 3,220,799 | |
| Capitalized research and development costs | |
| 2,421,390 | | |
| 2,362,939 | | |
| 2,199,126 | |
| Capitalized start-up costs | |
| 1,121,802 | | |
| 565,530 | | |
| 620,016 | |
| Capitalized licensing costs | |
| 687,926 | | |
| 689,820 | | |
| 735,485 | |
| Derivative liabilities | |
| - | | |
| - | | |
| 6,388 | |
| Capitalized patents | |
| 288,123 | | |
| 273,682 | | |
| 235,065 | |
| Warrants | |
| 133,203 | | |
| 238,768 | | |
| 239,307 | |
| Accrued payroll | |
| 71,830 | | |
| - | | |
| - | |
| Contributions carryforward | |
| 2,833 | | |
| 2,833 | | |
| 2,840 | |
| Lease liabilities | |
| 26,794 | | |
| - | | |
| - | |
| Deferred rent | |
| - | | |
| - | | |
| 4,176 | |
| Deferred tax assets | |
| 14,362,753 | | |
| 14,858,049 | | |
| 12,193,257 | |
| Valuation allowance | |
| - | | |
| (14,853,648 | ) | |
| (12,180,021 | ) |
| Deferred tax assets | |
| 14,362,753 | | |
| 4,401 | | |
| 13,236 | |
| | |
| | | |
| | | |
| | |
| Deferred debt discount | |
| - | | |
| - | | |
| (6,388 | ) |
| Right-of-use asset | |
| (24,236 | ) | |
| - | | |
| - | |
| In-process research and development | |
| (24,658,231 | ) | |
| - | | |
| - | |
| Fixed assets | |
| (4,270 | ) | |
| (4,401 | ) | |
| (6,848 | ) |
| Deferred tax liabilities | |
| (24,686,737 | ) | |
| (4,401 | ) | |
| (13,236 | ) |
| | |
| | | |
| | | |
| | |
| Deferred tax assets, net | |
$ | (10,323,984 | ) | |
$ | - | | |
$ | - | |
|